8-Chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-[1,2,4]triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide, with CAS number 50330-59-1, is a synthetic compound belonging to the benzodiazepine class, characterized by its complex heterocyclic structure. This substance features a triazole ring fused to a benzodiazepine framework, which contributes to its pharmacological properties. The presence of chlorine substituents enhances its lipophilicity and may influence its biological activity. Typically, compounds in this class exhibit anxiolytic, sedative, and anticonvulsant effects, making them of interest in medicinal chemistry. The dimethylamino group is likely to enhance the compound's solubility and bioavailability. As with many benzodiazepines, the compound may interact with the GABA-A receptor, leading to central nervous system effects. Its specific characteristics, such as melting point, solubility, and stability, would depend on the molecular interactions and the environment in which it is studied. Safety and handling precautions are essential due to potential toxicity and side effects associated with benzodiazepine derivatives.

8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-[1,2,4]triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide

50330-59-1: 8-Chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-[1,2,4]triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide, with CAS number 50330-59-1, is a synthetic compound belonging to the benzodiazepine class, characterized by its complex heterocyclic structure. This substance features a triazole ring fused to a benzodiazepine framework, which contributes to its pharmacological properties. The presence of chlorine substituents enhances its lipophilicity and may influence its biological activity. Typically, compounds in this class exhibit anxiolytic, sedative, and anticonvulsant effects, making them of interest in medicinal chemistry. The dimethylamino group is likely to enhance the compound's solubility and bioavailability. As with many benzodiazepines, the compound may interact with the GABA-A receptor, leading to central nervous system effects. Its specific characteristics, such as melting point, solubility, and stability, would depend on the molecular interactions and the environment in which it is studied. Safety and handling precautions are essential due to potential toxicity and side effects associated with benzodiazepine derivatives.

<p>Rilmazolam is a triazolobenzodiazepine compound and serves as the active metabolite of Rilmazafone.</p>

CAS 50330-59-1

8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-[1,2,4]triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide

Rilmazolam

Ref: TM-T203304